168 related articles for article (PubMed ID: 31097105)
21. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
Arfi A; Hequet D; Bataillon G; Tran-Perennou C; Farkhondeh F; Sastre-Garau X; Fourchotte V; Rouzier R; Laas E; Pouget N; Vincent-Salomon A; Jeannot E
BMC Cancer; 2019 Apr; 19(1):375. PubMed ID: 31014281
[TBL] [Abstract][Full Text] [Related]
22. Endocervical adenocarcinoma: selected diagnostic challenges.
Ronnett BM
Mod Pathol; 2016 Jan; 29 Suppl 1():S12-28. PubMed ID: 26715171
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.
Pirog EC; Kleter B; Olgac S; Bobkiewicz P; Lindeman J; Quint WG; Richart RM; Isacson C
Am J Pathol; 2000 Oct; 157(4):1055-62. PubMed ID: 11021808
[TBL] [Abstract][Full Text] [Related]
24. Histopathologic classification of cervical carcinomas and recognition of mucin-secreting squamous carcinomas.
Colgan TJ; Auger M; McLaughlin JR
Int J Gynecol Pathol; 1993 Jan; 12(1):64-9. PubMed ID: 8380284
[TBL] [Abstract][Full Text] [Related]
25. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
26. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ
Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124
[TBL] [Abstract][Full Text] [Related]
27. Cervical adenocarcinoma: a retrospective clinicopathologic study of 16 cases.
Barbu I; Crăiţoiu S; Mărgăritescu C
Rom J Morphol Embryol; 2012; 53(3):615-24. PubMed ID: 22990556
[TBL] [Abstract][Full Text] [Related]
28. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions.
Mikami Y; McCluggage WG
Adv Anat Pathol; 2013 Jul; 20(4):227-37. PubMed ID: 23752085
[TBL] [Abstract][Full Text] [Related]
29. Pattern based classification of endocervical adenocarcinoma: a review.
Park KJ; Roma AA
Pathology; 2018 Feb; 50(2):134-140. PubMed ID: 29241973
[TBL] [Abstract][Full Text] [Related]
30. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and prognostic significance of immunophenotypic characterization of endocervical adenocarcinoma using CLDN18, CDH17, and PAX8 in association with HPV status.
Asaka S; Nakajima T; Ida K; Asaka R; Kobayashi C; Ito M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2022 Feb; 480(2):269-280. PubMed ID: 34581850
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis and differential diagnosis of cervical adenocarcinoma].
Löning T; Riethdorf L; Köbel M
Pathologe; 2011 Nov; 32(6):505-13. PubMed ID: 22038135
[TBL] [Abstract][Full Text] [Related]
33. Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
Shi H; Shao Y; Zhang H; Ye L; Xu E; Lu B
Pathology; 2022 Aug; 54(5):555-562. PubMed ID: 35346505
[TBL] [Abstract][Full Text] [Related]
34. Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.
Park KJ; Roma A; Singh N; Gilks CB; Oliva E; Abu-Rustum N; Ramirez PT; McCluggage WG
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S92-S101. PubMed ID: 33570866
[TBL] [Abstract][Full Text] [Related]
35. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
Zhao C; Li Z; Austin RM
Am J Clin Pathol; 2013 Jul; 140(1):47-54. PubMed ID: 23765533
[TBL] [Abstract][Full Text] [Related]
36. Gastric-type Endocervical Adenocarcinoma: An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis.
Karamurzin YS; Kiyokawa T; Parkash V; Jotwani AR; Patel P; Pike MC; Soslow RA; Park KJ
Am J Surg Pathol; 2015 Nov; 39(11):1449-57. PubMed ID: 26457350
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas.
Chen L; Niu Y; Wan X; Yu L; Zhang X; Strickland AL; Dong L; Zhou F; Lu W
BMC Cancer; 2021 Oct; 21(1):1095. PubMed ID: 34635081
[TBL] [Abstract][Full Text] [Related]
38. Endocervical neoplasia: Pathologic updates in diagnosis and prognosis.
Rivera-Colón G; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):213-227. PubMed ID: 34953647
[TBL] [Abstract][Full Text] [Related]
39. The developing spectrum of gastric-type cervical glandular lesions.
Talia KL; McCluggage WG
Pathology; 2018 Feb; 50(2):122-133. PubMed ID: 29233547
[TBL] [Abstract][Full Text] [Related]
40. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
